AEON Biopharma, Inc. (AMEX:AEON) IPO
IPO
Went public as Priveterra Acquisition Corp., a blank check company (SPAC). Priced at US$10.00 a unit on Feb 8, 2021.
- Price
- US$10.00 a unit
- Units offered
- 24,000,000 units
- Offering size
- US$240 million
- Underwriters' option
- Up to 3,600,000 more units
- Listing
- PMGMU on the Nasdaq Capital Market
- Underwriters
- Wells Fargo Securities, Guggenheim Securities, Odeon Capital Group, LLC · In the order on the cover
- Units delivered
- On or about Feb 11, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Dec 23, 2020 |
| Filed publicly | Jan 21, 2021 |
| Amended once | Jan 29, 2021 |
| Shares registered with an exchange | Feb 8, 2021 |
| Declared effective by the SEC | Feb 8, 2021 |
| Final prospectus, with the price | Feb 11, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Feb 11, 2021 |
| S-1MEF · Registration of more shares for the same offering | Feb 9, 2021 |
| EFFECT · Notice that a registration is effective | Feb 8, 2021 |
| CERT · Exchange's certificate of listing | Feb 8, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Feb 8, 2021 |
| S-1/A · Registration statement, amended | Jan 29, 2021 |
| S-1 · Registration statement | Jan 21, 2021 |
| DRS · Draft registration statement | Dec 23, 2020 |
From the cover of the final prospectus (424B4) filed Feb 11, 2021